Hyaluronic Acid Crosslinking Clinical Study
NCT: NCT07744464 · ACTIVE_NOT_RECRUITING
Brief Summary
This prospective observational case series aims to evaluate the clinical efficacy, safety, and patient satisfaction associated with hyaluronic acid dermal fillers with different degrees of divinyl sulfone (DVS) crosslinking. Twenty adult participants undergoing facial aesthetic treatment will be followed for 90 days. Clinical outcomes will be assessed using three-dimensional imaging (Vectra® 3D), soft tissue ultrasonography, the Global Aesthetic Improvement Scale (GAIS), Net Promoter Score (NPS), Likert satisfaction scales, and standardized adverse event monitoring.
Frequently Asked Questions
What is Hyaluronic Acid Crosslinking Clinical Study?
Hyaluronic Acid Crosslinking Clinical Study is a clinical trial registered under NCT07744464. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT07744464?
The current status of NCT07744464 (Hyaluronic Acid Crosslinking Clinical Study) is: ACTIVE_NOT_RECRUITING.
When did Hyaluronic Acid Crosslinking Clinical Study start?
Hyaluronic Acid Crosslinking Clinical Study started on 2026-03-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.